61 results
Page 3 of 4
6-K
EX-99.1
zrbg61gt0 f1
12 Jul 21
New post-hoc analyses of data from SELECTION Phase 3 program presented at European Crohn’s and Colitis Organisation (ECCO) virtual congress
9:02am
6-K
EX-99.1
llogi
4 Jun 21
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
6:05am
6-K
EX-99.1
rzl2oxtsr
28 May 21
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress
6:00am
6-K
EX-99.1
fvc qjon67nh1i
19 May 21
Current report (foreign)
6:00am
6-K
EX-99.3
d1m8p2xheom yqvcdl
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.2
6au6pvn5wsifm
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
wgck o98y51rm
6 Jan 21
Galapagos to present at 39th Annual J.P. Morgan Healthcare Conference
9:57am
6-K
EX-99.2
oquzxbf
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.1
0bmtyyh5gyub1
26 Aug 20
Galapagos to present new insights in IPF and related clinical developments at the European Respiratory Society Congress
6:37am
6-K
EX-99.1
7qc 0nvcwfu
10 Jan 20
Galapagos to present at 38th Annual J.P. Morgan Healthcare Conference
6:14am
6-K
EX-99.3
o6k3ympb e8
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.1
nt5wv1
26 Dec 18
Galapagos to Present at 37th Annual J.P. Morgan Healthcare Conference
6:09am
6-K
EX-99.1
s0i96pl5
22 May 18
GLPG1690 results in IPF published in The Lancet Respiratory Medicine and presented at ATS
6:00am
20-F
wt76h 7dml
25 Mar 16
Annual report (foreign)
12:00am
DRS
1ocsh xvqrq8
6 Feb 15
Draft registration statement
12:00am